Status:
RECRUITING
Bipolar Resection vs Enucleation of Prostate
Lead Sponsor:
South Valley University
Conditions:
Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection
Benign Prostatic Hyperplasia With Outflow Obstruction
Eligibility:
MALE
50-80 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate efficacy and safety of transurethral resection of the prostate and bipolar enucleation of the prostate.
Detailed Description
Endoscopic management of benign prostatic hyperplasia (BPH), monopolar transurethral resection of the prostate (TURP) has been the gold standard for many years. Despite its promising efficacy in trea...
Eligibility Criteria
Inclusion
- Patients with lower urinary tract symptoms (LUTS) due to BPH.
- Patients with international prostate score system (IPSS) more than 8.
- Patients with maximal urinary flow rate (Qmax) less than 10ml/second.
- Patients with Prostatic volume (60 - 100 gm).
- Patient with indication for surgical intervention.
- Patient age (50-80 years old)
Exclusion
- Prostatic cancer.
- Bladder cancer.
- Urethral stricture.
- Neurogenic bladder.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06983444
Start Date
June 1 2025
End Date
July 1 2026
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine South Valley University
Qina, Qena Governorate, Egypt, 83523